Working to Cure HIV at Temple

Healthcare Innovation Panel: Working to Cure HIV at Temple – How do Innovations Like this Occur and How Does the Philadelphia Ecosystem Contribute to Bringing This Type of Discovery to the Market?

Using a discovery made at Temple University in Philadelphia, Dr. Kamel Khalili and the team at Excision BioTherapeutics have eliminated HIV from infected animals. This is the first study of its kind, and it was recently published in Nature Communications. Temple will host a panel including key inventors, administrators, and angel investors, discussing the fundamental discoveries that led to this breakthrough and the role Temple University and other members of our innovation ecosystem play in helping to commercialize discoveries like this.

Kamel Khalili, PhD
Director
Katie Beddis
Senior Director of Development
Stephen Nappi
Associate Vice President of Technology Commercialization and Business Development
John Prendergass
Associate Director of the Health & Digital Health Investment Group
Event Details
  • Start Date
    October 15, 2019 9:00 am
  • End Date
    October 15, 2019 10:00 am
  • Venue
    • Charles Library, Room 102
  • Address
    1900 North 13th Street, Philadelphia, PA 19122